World ADC 2017

Quality Assistance attended the 7th annual World ADC Berlin !

World ADC Berlin is Europe’s longest running and most detailed antibody-drug conjugate conference. Each year, over 300 of our peers unite at this industry focused summit to immerse themselves in cutting-edge ADC science. Across 3 days, this comprehensive 3 streamed programme covered every element of ADCs from discovery, development, manufacturing and clinical.

At the 7th World ADC, 56 industry experts presented ground-breaking scientifically novel ADC research on warheads with differentiated mechanism of action, tools for improving interpretation of PK data, more robust clinical dosing strategies and processes for scaling up bio-conjugation.

Ms Nathalie Draux, Chief Operations Officer, Ms Tatyana Hrechdakian & Dr Arnaud Delobel, R&D Director were delighted to meet you !

You also had the opportunity to attend Dr Arnaud Delobel oral presentation :

Conference Day One | Tuesday 21st February 2017 
Development Stream 

12.00 Advances in Mass Spectrometry for the Characterisation & Bioanalysis of ADCs

by Arnaud Delobel, R&D Director, Quality Assistance

• Multi-level characterisation by 1D and 2D-LC/M
• Fine characterisation using a peptide mapping approach with ETD fragmentation
• Bioanalysis of ADCs using immunoaffinity mass spectrometry

The slides are available here

Venue:

More info and registration:

World ADC website